User talk:Lalita Vempati

This is Lalita Vempati's talk page, where you can send them messages and comments.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Your submission at Articles for creation: Clinical Trials Oversight System (August 12)

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reasons left by Timtrent were:

Please read and make this conform to WP:MOS, then find multiple excellent references and rewrite for tone, using the references as you go We require references from significant coverage about the topic of the article, and independent of it, and in WP:RS please. See WP:42. Please also see WP:PRIMARY which details the limited permitted usage of primary sources and WP:SELFPUB which has clear limitations on self published sources. Providing sufficient references, ideally one per fact referred to, that meet these tough criteria is likely to make this draft a clear acceptance (0.9 probability). Lack of them or an inability to find them is likely to mean that the topic is not suitable for inclusion, certainly today.

This submission reads more like an essay than an encyclopedia article. Submissions should summarise information in secondary, reliable sources and not contain opinions or original research. Please write about the topic from a neutral point of view in an encyclopedic manner.

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.

If you would like to continue working on the submission, go to Draft:Clinical Trials Oversight System and click on the "Edit" tab at the top of the window.
If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Clinical Trials Oversight System, click on the "Edit" tab at the top of the window, add "{{Db-g7}}" at the top of the draft text and click the blue "publish changes" button to save this edit.
If you do not make any further changes to your draft, in 6 months, it will be considered abandoned and may be deleted.
If you need any assistance, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

Fiddle Faddle 15:04, 12 August 2020 (UTC)[reply]

Hello, Lalita Vempati! Having an article declined at Articles for Creation can be disappointing. If you are wondering why your article submission was declined, please post a question at the Articles for creation help desk. If you have any other questions about your editing experience, we'd love to help you at the Teahouse, a friendly space on Wikipedia where experienced editors lend a hand to help new editors like yourself! See you there! Fiddle Faddle 15:04, 12 August 2020 (UTC)[reply]

AfC notification: Draft:Clinical Trials Oversight System has a new comment

I've left a comment on your Articles for Creation submission, which can be viewed at Draft:Clinical Trials Oversight System. Thanks! Noahfgodard (talk) 15:37, 17 November 2020 (UTC)[reply]

Your submission at Articles for creation: Clinical Trials Oversight System (December 1)

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Primefac was:

This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.

The comment the reviewer left was:

Zero sources. Please add additional independent reliable sources that discuss the subject in detail.

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.

If you would like to continue working on the submission, go to Draft:Clinical Trials Oversight System and click on the "Edit" tab at the top of the window.
If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Clinical Trials Oversight System, click on the "Edit" tab at the top of the window, add "{{Db-g7}}" at the top of the draft text and click the blue "publish changes" button to save this edit.
If you do not make any further changes to your draft, in 6 months, it will be considered abandoned and may be deleted.
If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

Primefac (talk) 23:13, 1 December 2020 (UTC)[reply]

December 2020

Hello, Lalita Vempati. This is your user talk page; the purpose of this page is for notification and communication with other Wikipedia editors. It is not a workspace for articles in progress or self-promotion. Please use your user sandbox or the draft article space to practice editing or create new articles. Thank you. Drm310 🍁 (talk) 08:27, 23 December 2020 (UTC)[reply]

Thank you. Lalita Vempati (talk) 09:39, 23 December 2020 (UTC)[reply]

Hello Lalita Vempati. The nature of your edits, such as the one you made to Hexaware, gives the impression you have an undisclosed financial stake in promoting a topic, but you have not complied with Wikipedia's mandatory paid editing disclosure requirements. Paid advocacy is a category of conflict of interest (COI) editing that involves being compensated by a person, group, company or organization to use Wikipedia to promote their interests. Undisclosed paid advocacy is prohibited by our policies on neutral point of view and what Wikipedia is not, and is an especially serious type of COI; the Wikimedia Foundation regards it as a "black hat" practice akin to black-hat search-engine optimization.

Paid advocates are very strongly discouraged from direct article editing, and should instead propose changes on the talk page of the article in question if an article exists. If the article does not exist, paid advocates are extremely strongly discouraged from attempting to write an article at all. At best, any proposed article creation should be submitted through the articles for creation process, rather than directly.

Regardless, if you are receiving or expect to receive compensation for your edits, broadly construed, you are required by the Wikimedia Terms of Use to disclose your employer, client and affiliation. You can post such a mandatory disclosure to your user page at User:Lalita Vempati. The template {{Paid}} can be used for this purpose – e.g. in the form: {{paid|user=Lalita Vempati|employer=InsertName|client=InsertName}}. If I am mistaken – you are not being directly or indirectly compensated for your edits – please state that in response to this message. Otherwise, please provide the required disclosure. In either case, do not edit further until you answer this message. Justlettersandnumbers (talk) 17:08, 30 December 2020 (UTC)[reply]

Thank you. I would like to clarify that I am not being paid to create this or any other page on Wikipedia. Please let me know if I can continue to edit the page for the copyright issues raised. Lalita Vempati (talk) 06:18, 31 December 2020 (UTC)[reply]

Copyright problem: Hexaware

Hello, and welcome to Wikipedia! We welcome and appreciate your contributions, such as Hexaware, but we regretfully cannot accept copyrighted text or images from either web sites or printed works. This article appears to contain work copied from https://de.reuters.com/finance/stocks/company-profile/HEXT.NS https://web.archive.org/web/20090220174111/https://www.moneycontrol.com/stocks/company_info/company_history.php?sc_did=ht02, and therefore to constitute a violation of Wikipedia's copyright policies. The copyrighted text has been or will soon be deleted. While we appreciate contributions, we must require all contributors to understand and comply with our copyright policy. Wikipedia takes copyright violations very seriously, and persistent violators are liable to be blocked from editing.

If you believe that the article is not a copyright violation, or if you have permission from the copyright holder to release the content freely under license allowed by Wikipedia, then you should do one of the following:

Have the author release the text under the Creative Commons Attribution-ShareAlike 3.0 License (CC BY-SA 3.0) by leaving a message explaining the details at Talk:Hexaware and send an email with confirmation of permission to "permissions-en (at) wikimedia (dot) org". Make sure they quote the exact page name, Hexaware, in their email. See Wikipedia:Requesting copyright permission for instructions.
If you hold the copyright to the work: send an e-mail from an address associated with the original publication to permissions-enwikimedia.org or a postal message to the Wikimedia Foundation permitting re-use under the Creative Commons Attribution-ShareAlike 3.0 License and GNU Free Documentation License, and note that you have done so on Talk:Hexaware. See Wikipedia:Donating copyrighted materials for instructions.
If a note on the original website states that re-use is permitted "under the Creative Commons Attribution-ShareAlike License (CC-BY-SA), version 3.0", or that the work is released into the public domain, or if you have strong reason to believe it is, leave a note at Talk:Hexaware with a link to where we can find that note or your explanation of why you believe the content is free for reuse.

It may also be necessary for the text to be modified to have an encyclopedic tone and to follow Wikipedia article layout. For more information on Wikipedia's policies, see Wikipedia's policies and guidelines.

See Wikipedia:Declaration of consent for all enquiries for a template of the permissions letter the copyright holder is expected to send.

If you would like to begin working on a new version of the article you may do so at this temporary page. Leave a note at Talk:Hexaware saying you have done so and an administrator will move the new article into place once the issue is resolved.

Thank you, and please feel welcome to continue contributing to Wikipedia. Happy editing! Justlettersandnumbers (talk) 17:07, 30 December 2020 (UTC)[reply]

Speedy deletion of User:Lalita Vempati/Hexaware

If this was the first article that you created, you may want to read the guide to writing your first article.
You may want to consider using the Article Wizard to help you create articles.

The page User:Lalita Vempati/Hexaware has been speedily deleted from Wikipedia. This was done under section G12 of the criteria for speedy deletion, because the page appeared to be an unambiguous copyright infringement. This page appeared to be a direct copy from https://web.archive.org/web/20090220174111/https://www.moneycontrol.com/stocks/company_info/company_history.php?sc_did=ht02 and https://de.reuters.com/finance/stocks/company-profile/HEXT.NS. For legal reasons, we cannot accept copyrighted text or images taken from other web sites or printed material, and as a consequence, your addition has been be deleted. You may use external websites or other printed material as a source of information, but not as a source of sentences. This part is crucial: say it in your own words. Wikipedia takes copyright violations very seriously and persistent violators will be blocked from editing.

If the external website or image belongs to you, and you want to allow Wikipedia to use the text or image — which means allowing other people to use it for any reason — then you must verify that externally by one of the processes explained at Wikipedia:Donating copyrighted materials. The same holds if you are not the owner but have their permission. If you are not the owner and do not have permission, see Wikipedia:Requesting copyright permission for how you may obtain it. You might want to look at Wikipedia's copyright policy for more details, or ask a question here.

Please do not recreate the material without addressing these concerns, but do not hesitate to add information in line with Wikipedia's policies and guidelines. If you think this page should not have been deleted for this reason, you may contact the deleting administrator, or if you have already done so, you may open a discussion at Wikipedia:Deletion Review Justlettersandnumbers (talk) 11:40, 5 January 2021 (UTC)[reply]

Concern regarding Draft:Clinical Trials Oversight System

Hello, Lalita Vempati. This is a bot-delivered message letting you know that Draft:Clinical Trials Oversight System, a page you created, has not been edited in at least 5 months. Draft space is not an indefinite storage location for content that is not appropriate for article space.

If your submission is not edited soon, it could be nominated for deletion under CSD G13. If you would like to attempt to save it, you will need to improve it. You may request userfication of the content if it meets requirements.

If the deletion has already occured, instructions on how you may be able to retrieve it are available here.

Thank you for your submission to Wikipedia. FireflyBot (talk) 00:03, 4 May 2021 (UTC)[reply]

Your draft article, Draft:Clinical Trials Oversight System

Hello, Lalita Vempati. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "Clinical Trials Oversight System".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been deleted. If you plan on working on it further and you wish to retrieve it, you can request its undeletion. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thanks for your submission to Wikipedia, and happy editing. Liz ^{Read! Talk!} 23:14, 1 June 2021 (UTC)[reply]